Uncategorized

KHN’s ‘What the Health?’: Our 200th Episode!

Posted on

The federal approval of a controversial drug to treat Alzheimer’s disease has reignited the debate over drug prices and the way the Food and Drug Administration makes decisions. Meanwhile, President Joe Biden seeks to gain goodwill overseas as he announces the U.S. will provide 500 million doses of covid vaccine to international health efforts. Sarah Karlin-Smith of the Pink Sheet, Margot Sanger-Katz of The New York Times and Joanne Kenen of Politico join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews Chiquita Brooks-LaSure, the new administrator of the Centers for Medicare & Medicaid Services. And to mark the podcast’s 200th episode, the panelists discuss what has surprised them most and least over the past four years.

Uncategorized

For $39 A Month, This ‘Woebot’ May Fill Gaps For Patients Who Can’t See A Therapist

Posted on

The creators of the chatbot see it as a way to help patients when a therapist isn’t available. “You can access it when you need it most,” says former Stanford researcher Alison Darcy. “If it’s 2 a.m. and you’re having a panic attack, a physician isn’t going to be available at that time.” Meanwhile, researchers find that wireless “smart” pill bottles don’t really do anything to help people remember to take their medicine.